Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.49M Sell
78,300
-97,100
-55% -$1.88M ﹤0.01% 2863
2025
Q4
$2.87M Sell
175,400
-44,900
-20% -$790K ﹤0.01% 2143
2025
Q3
$4.14M Buy
220,300
+72,100
+49% +$1.29M ﹤0.01% 1703
2025
Q2
$2.99M Sell
148,200
-35,800
-19% -$619K ﹤0.01% 1739
2025
Q1
$2.53M Buy
184,000
+117,700
+178% +$1.62M ﹤0.01% 1652
2024
Q4
$786K Buy
66,300
+27,100
+69% +$427K ﹤0.01% 2506
2024
Q3
$703K Buy
+39,200
New +$715K ﹤0.01% 2233
2024
Q2
Sell
-118,900
Closed -$3.05M 2829
2024
Q1
$3.05M Buy
118,900
+6,300
+6% +$158K ﹤0.01% 1170
2023
Q4
$2.94M Buy
112,600
+59,700
+113% +$1.36M ﹤0.01% 1059
2023
Q3
$1.22M Buy
+52,900
New +$1.33M ﹤0.01% 1152

Other funds holding XP

IMC Chicago's XP Position: Q1 2026 in Review

IMC Chicago reduced its XP (XP) stake by 86% in Q1 2026, selling an estimated $2.21M and leaving 18,406 shares worth $350K. The position accounts for ﹤0.01% of the portfolio, ranked #4408.

IMC Chicago first reported a position in XP in Q4 2024 and has held it in 5 quarters since. The position peaked at $2.18M in Q4 2025. 356 funds tracked by Wall St. Rank hold XP as of Q1 2026.

  • IMC Chicago held 18,406 shares of XP worth $350K as of Q1 2026.
  • IMC Chicago sold 114,539 XP shares in Q1 2026, an estimated $2.21M.
  • XP made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #4408 holding.
  • IMC Chicago first reported a position in XP in Q4 2024 and has held it in 5 quarters since.
  • IMC Chicago's XP position peaked at $2.18M in Q4 2025.
  • 356 funds tracked by Wall St. Rank held XP as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.